Featured Research

from universities, journals, and other organizations

Heart attack patients in states with public reporting less likely to receive angioplasty

Date:
October 9, 2012
Source:
Harvard School of Public Health
Summary:
Patients entering hospitals with heart attacks in states with mandatory public reporting are less likely to receive angioplasties to fix heart blockages than patients in states without public reporting, according to a new study.

Patients entering hospitals with heart attacks in states with mandatory public reporting are less likely to receive angioplasties to fix heart blockages than patients in states without public reporting, according to a new study from Harvard School of Public Health. The patients most affected were those considered "high-risk," that is, those who were extremely sick when they arrived at the hospital. It is the first study to look at public reporting for these interventions on a national level. The study appears in the October 10, 2012 edition of the Journal of the American Medical Association.

"Making performance data available to patients is very important. It helps them choose the best health care," said Karen Joynt, instructor in the Department of Health Policy and Management at HSPH and a physician at Brigham and Women's Hospital in Boston. However, the results of our study make us wonder if we're doing public reporting as well as we could be."

Public reporting is an increasingly popular strategy for improving health care. While currently only three states require public reporting of patient outcomes after percutaneous coronary intervention (PCI, more commonly referred to as stenting or angioplasty, a procedure in which balloons and stents are inserted into heart arteries to fix blockages), many states have voluntary reporting programs, and many more are considering implementing such programs. The idea is simple -- if hospital performance is made public, patients can have information to choose the best hospital and clinicians will be motivated to improve performance. However, a worry is that if hospitals are concerned about receiving negative ratings in public reports, they will be less inclined to offer these procedures to very sick patients.

The researchers, led by Joynt and Ashish Jha, associate professor of health policy and management at HSPH and a staff physician at the VA Boston Healthcare System, analyzed data from patients older than 65 years of age who had suffered heart attacks in Massachusetts, New York, and Pennsylvania, three public reporting states, from 2002-2010. They compared the patients in those three states with patients in seven non-reporting states in the same region.

The results showed that overall, Medicare patients with heart attacks in those three states had 18% lower odds of receiving PCI than patients in states without public reporting. The results were even more striking for extremely sick patients -- those arriving at a hospital with a massive heart attack had about 27% lower odds and those arriving in cardiac arrest or in shock had about 21% lower odds of receiving PCI than comparable patients in other states. In Massachusetts, which implemented public reporting relatively recently, the odds of receiving PCI, relative to other states, dropped 19% after the public reporting program started.

The researchers note that there are at least two possible explanations for the study results. One is that physicians were concerned about the risk of poor outcomes if they performed PCIs on patients who were very ill. However, it is also possible that physicians did not perform PCIs because the procedures were futile or unnecessary. "It will be important for follow-up work to determine why this is going on, and more importantly, how we can address it," said Joynt.

This study raises a caution flag, said Jha. Many states are considering implementing reporting programs and many have put voluntary programs in place. Policies may need to be evaluated with the same rigor that new drugs, devices, or therapies are evaluated, he said.

"Improving transparency of the health care system is critical," Jha said. "However, we have to make sure we do it right. Otherwise we risk creating incentives to deny care to the sickest patients."


Story Source:

The above story is based on materials provided by Harvard School of Public Health. Note: Materials may be edited for content and length.


Journal Reference:

  1. Karen E. Joynt, Daniel M. Blumenthal, E. John Orav, Frederic S. Resnic, Ashish K. Jha. Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction. JAMA, October 10, 2012, Vol. 308, No. 14

Cite This Page:

Harvard School of Public Health. "Heart attack patients in states with public reporting less likely to receive angioplasty." ScienceDaily. ScienceDaily, 9 October 2012. <www.sciencedaily.com/releases/2012/10/121009161055.htm>.
Harvard School of Public Health. (2012, October 9). Heart attack patients in states with public reporting less likely to receive angioplasty. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/10/121009161055.htm
Harvard School of Public Health. "Heart attack patients in states with public reporting less likely to receive angioplasty." ScienceDaily. www.sciencedaily.com/releases/2012/10/121009161055.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins